Cann Group (ASX:CAN) has signed a deal with Levin Health for the supply of medicinal cannabis products between July and December 2023.

The cannabis medicines company said the 6-month agreement is worth approximately $880,000.

It also said as part of the deal, Cann will supply dried flower and oil from its state-of-the-art facility in Mildura.

Shares of Cann Group were up 4% at 2pm AEST.